| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.32 | 0.4 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |